Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma. | Front Pharmacol | 2023 | 37113755 | PubTator, text mining | PubMed |
| CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor. | Pharmaceuticals (Basel) | 2023 | 37111350 | PubTator, text mining | PubMed |
| How to Understand Personalized Medicine in Atopic Dermatitis Nowadays? | Int J Mol Sci | 2023 | 37108720 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting. | Int J Mol Sci | 2023 | 37108657 | PubTator, text mining | PubMed |
| Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer. | Int J Mol Sci | 2023 | 37108425 | PubTator, text mining | PubMed |
| Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies. | Int J Mol Sci | 2023 | 37108348 | PubTator, text mining | PubMed |
| Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37108109 | PubTator, text mining | PubMed |
| Uterine Transcriptome: Understanding Physiology and Disease Processes. | Biology (Basel) | 2023 | 37106834 | PubTator, text mining | PubMed |
| Impact of structural-level environmental interventions on physical activity: a systematic review. | Int Arch Occup Environ Health | 2023 | 37099193 | PubTator, text mining | PubMed |
| Culture-expanded mesenchymal stromal cell therapy: does it work in knee osteoarthritis? A pathway to clinical success. | Cell Mol Immunol | 2023 | 37095295 | PubTator, text mining | PubMed |
| The Identification and Clinical Value Evaluation of CYCS Related to Asthma through Bioinformatics Analysis and Functional Experiments. | Dis Markers | 2023 | 37091894 | PubTator, text mining | PubMed |
| Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment. | Front Genet | 2023 | 37091783 | PubTator, text mining | PubMed |
| Potential of resveratrol in the treatment of interstitial lung disease. | Front Pharmacol | 2023 | 37089962 | PubTator, text mining | PubMed |
| Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy. | Front Pharmacol | 2023 | 37089933 | PubTator, text mining | PubMed |
| Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal polyps. | Sci Rep | 2023 | 37085563 | PubTator, text mining | PubMed |
| A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction. | Microb Genom | 2023 | 37083600 | PubTator, text mining | PubMed |
| Advances in the role of STAT3 in macrophage polarization. | Front Immunol | 2023 | 37081874 | PubTator, text mining | PubMed |
| Landscape of gene mutation in Chinese thyroid cancer patients: Construction and validation of lymph node metastasis prediction model based on clinical features and gene mutation marker. | Cancer Med | 2023 | 37081757 | PubTator, text mining | PubMed |
| Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma. | Cell Oncol (Dordr) | 2023 | 37079186 | PubTator, text mining | PubMed |
| Macrophages and stem/progenitor cells interplay in adipose tissue and skeletal muscle: a review. | Stem Cell Investig | 2023 | 37077316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=37